Related Experiment Video
Updated: Oct 30, 2025

The Dyspepsia Educational Tool As a Novel Aid in Dyspepsia Management
Published on: June 29, 2019
[Significant over- and misuse of PPIs]
Lars Agreus1, Lars Borgquist2, Alexandros Tsoposidis3
1institutionen för neurobiologi, vårdvetenskap och samhälle, Karolinska institutet, Stockholm; Öregrunds vårdcentral, professor emeritus, distriktsläkare.
Proton-pump inhibitors (PPIs) effectively treat acid-related diseases but are often overused. Addressing PPI misuse is crucial to reduce healthcare costs and long-term adverse effects.
Area of Science:
- Gastroenterology
- Pharmacology
Background:
- Proton-pump inhibitors (PPIs) are primary treatments for acid-related gastrointestinal disorders.
- Common indications include GERD, H. pylori eradication, peptic ulcer healing, NSAID-induced lesions, and hypersecretory conditions like Zollinger-Ellison syndrome.
Purpose of the Study:
- To analyze the prevalent over- and misuse of PPIs in healthcare settings.
- To identify the consequences of PPI overprescription, including increased costs and adverse side effects.
Main Methods:
- Review of current prescribing practices and recognized reasons for PPI over- and misuse.
- Analysis of the impact of PPI overprescription on medical costs and patient safety.
Main Results:
- Significant over- and misuse of PPIs are prevalent in both hospital and general practice settings.
- Overprescription leads to escalating medical expenses and heightened risks of long-term adverse effects.
Conclusions:
- Physician and patient education on appropriate PPI use is essential.
- Promoting balanced and evidence-based PPI prescription is key to mitigating risks and optimizing patient outcomes.
More Related Videos
05:23Gastric Mucosa Quantitative Polymerase Chain Reaction Analysis for Detecting Helicobacter pylori and Antibiotic Resistance
Published on: March 7, 2025
10:44One-step Negative Chromatographic Purification of Helicobacter pylori Neutrophil-activating Protein Overexpressed in Escherichia coli in Batch Mode
Published on: June 18, 2016
Related Concept Videos
Acid Suppressive Drugs for Peptic Ulcer Disease: Proton Pump Inhibitors
Gastric acid, a potent cocktail of hydrogen and chloride ions, is produced in specialized parietal cells within the...
Peptic Ulcer Disease IV: Management
The therapeutic approach involves ensuring adequate rest, implementing drug therapy, promoting smoking cessation, making dietary modifications, and emphasizing long-term follow-up care.
Pharmacological management
The prevailing therapy for peptic ulcers involves a combination of managing the patient's current...
Pathophysiology of Peptic Ulcer Disease: Mucosal Defense Factors
Peptic Ulcer Disease I: Introduction
An acute ulcer, marked by superficial erosion and minimal inflammation, swiftly resolves upon identifying and addressing the underlying cause. In contrast, a chronic ulcer persists, potentially eroding through the muscular wall and forming fibrous tissue.
Peptic ulcers can also be...
Drugs for Peptic Ulcer Disease: Prostaglandin Analogs as Mucosal Protective Agents
Non-steroidal anti-inflammatory drugs (NSAIDs) can induce peptic ulcers by inhibiting cyclooxygenase, decreasing...
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy